Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.
NCT ID: NCT05312281
Last Updated: 2022-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2022-06-28
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Instr. vs. Non-instr. Posterolateral Spinal Fusion in Patients With Spinal Stenosis and Degenerative Listhesis
NCT04166981
Lumbar Intervertebral Disc Herniation
NCT02110186
Decompression Versus Instrumented Fusion for Lumbar Degenerative Disease. Clinical and Biomechanical Outcome Study
NCT06335511
Dynamic Stabilization for Lumbar Spinal Stenosis With Stabilimax NZ® Dynamic Spine Stabilization System
NCT00529997
Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages
NCT05237908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A study by Prateepavanich et al. from 2001 shows advantages in the therapy with lumbar orthoses in neurogenic spinal claudication in the context of conservative therapy (9). Regarding postoperative prescription, expert opinions have long diverged (10). Nevertheless, in a survey of North American spine surgeons, over 60% reported prescribing an orthosis postoperatively (11).
2 Aim of the study
The aim of this study is to show that patients after surgical decompression for lumbar spinal stenosis and patients after surgical sequestrectomy benefit from temporary postoperative immobilization using a lumbar orthosis.
To show that postoperative therapy with a lumbar orthosis prolongs walking distance and reduces early recurrence.
It will be shown that postoperative pain decreases significantly faster and thus pain medication can be reduced faster early postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group "without lumbar belt"
Control group "without lumbar belt"
No interventions assigned to this group
Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo
Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo
Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo
Wear for 6 weeks post-surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device : Lombastab immo. wear for 6 weeks post-surgery the Lombastab Immo
Wear for 6 weeks post-surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 20-80 years
* Pre-operative walking distance at least 100m
* Consent form signed by the patient
Exclusion Criteria
* Tumors of the spine
* Cervical spinal stenosis or myelopathy
* Rheumatoid arthritis or similar autoimmune disease
* Infection - request for a pension
* Dyspnea due to heart failure with limited walking distance
* Peripheral Arterial Occlusive Disease (PAOD)-
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SRH Gesundheitszentrum Bad Herrenalb
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Veihelmann, Prof
Role: STUDY_CHAIR
SRH Ges.-Zentrum Bad Herrenalb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Karlsruhe
Karlsruhe, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GBH-O1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.